Clinical Trial Update: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial comparing obinutuzumab to rituximab in children with steroid-dependent or frequently relapsing nephrotic syndrome is currently recruiting, ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome in Children
• Steroid-dependent Nephrotic Syndrome
• Steroid-sensitive Nephrotic Syndrome

Drugs mentioned

• Obinutuzumab (obinutuzumab)
• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Steroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome | Phase 2, Phase 3 | Status: RECRUITING